Evaluation of Hemoglobinopathies in Anemic Patient Using Red Cell Indices from a Five-Part Differential Cell Counter and HPLC Estimation of Abnormal Hemoglobin

  • Home
  • Evaluation of Hemoglobinopathies in Anemic Patient Using Red Cell Indices from a Five-Part Differential Cell Counter and HPLC Estimation of Abnormal Hemoglobin

Evaluation of Hemoglobinopathies in Anemic Patient Using Red Cell Indices from a Five-Part Differential Cell Counter and HPLC Estimation of Abnormal Hemoglobin

1Dr. Zeenath begum, 2Dr. Zoya Riyaz Syeda, 3Dr. Asra Fatima, 4Bubli Soniya Kusha, 5Qurrath Ul Ain, 6Dr. Mandakini B. Tengli, 7Nabil afnan
1,2,3,4,5,6,7Khaja Bandenawaz University- Faculty of Medical Sciences.

REFERENCES

1) Fucharoen.S, Winichagoon.P, Wisedpanichkij. R, Sae-ngow.B, Sriphanich.R, Oncoung.W. Prenatal and postnatal diagnoses of thalassemia and hemoglobinopathies by HPLC. Clinical chemistry. 1998; 44:4-740.
2) Mia, Md Babu & Sadiya, Salma & Akhter, Nilufa & Sarwardi, Golam & Banu, Bilquis & Khan, Waqar. (2015). Role of RBC Indices in Screening of Thalassaemia and other Haemoglobinopathies in Children. 31. 99-106.
3) Amani Abu-Shaheen, Humariya Heena, Abdullah Nofal, Doaa A. Abdelmoety, Abdulrahman Almatary, Mohammed Alsheef, Isamme Al Fayyad, “Epidemiology of Thalassemia in Gulf Cooperation Council Countries: A Systematic Review”, BioMed Research International, vol. 2020, Article ID 1509501, 15 pages, 2020. https://doi.org/10.1155/2020/1509501.
4) Sinha S, Black ML, Agarwal S, Colah R, Das R, Ryan K, Bellgard M, Bittles AH. Profiling βthalassaemia mutations in India at state and regional levels: implications for genetic education, screening and counselling programmes. Hugo J. 2009 Dec;3(1-4):51-62. DOI: 10.1007/ s11568-010- 9132-3. Epub 2010 Feb 10. PMID: 21119755; PMCID: PMC2882644.
5) Shivashankara A.R, Jailkhani R, Kini A. Hemoglobinopathies In Dharwad, North Karnataka: A Hospital-based Study. Journal of Clinical and Diagnostic Research [serial online] 2008 February [cited: 2008 February 4]; 2:593-599.Available from http://www.jcdr.net/back_issues.asp?issn=0973- 709x&year=2008&month= February.
6) GD, Kulkarni SS, Kadakol GS, Kulkarni BB, Kyamangoudar PH, Lakkakula BV, Thangaraj K, Shepur TA, Kulkarni ML, Gai PB. Molecular basis of β-thalassemia in Karnataka, India. Genet Test Mol Biomarkers. 2012 Feb;16(2):138-41. doi: 10.1089/gtmb.2011.0035. Epub 2011 Oct 6. PMID: 21978377.
7) Abd Rahim MR, Kho SL, Kuppusamy UR, Tan JA. Non-Invasive DNA Sampling for Molecular Analysis of Beta-Thalassemia: Amiable Alternative Sampling Methods with Accurate Results for Pediatric Patients. Clin Lab. 2015;61(9):1325-30. doi: 10.7754/clin.lab.2015.150218. PMID: 26554253.
8) Piel, F. B., Hay, S. I., Gupta, S., Weatherall, D. J., & Williams, T. N. (2017). Global burden of sickle cell anaemia in children under five, 2010–2050: Modelling based on demographics, excess mortality, and interventions. PLoS Medicine. 2017; 10(7).
9) World Health Organization (WHO).Sickle-cell anaemia: Report by the Secretariat.2006
10) Angastiniotis, M, Modell, B. Global epidemiology of hemoglobin disorders. Ann N Y Acad Sci. 1998;850(1): 251-269.


  • Share

Leave a Reply

Your email address will not be published. Required fields are marked *